Catalyst Wire Dossier Catalyst Wire Dossier

Deucrictibant

Deucrictibant · Institute for Asthma and Allergy
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Deucrictibant, covering 2025-07-02 to 2025-11-21. Get the full timeline:

Most recent: Clinical Trial Update: Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema [Phase 3]

See pricing